Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy

Sponsor
Emory University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03939819
Collaborator
(none)
125
1
2
54.1
2.3

Study Details

Study Description

Brief Summary

This study aims to compare the difference in staple usage and post-operative GERD (heartburn) between patients that had an endoscope used versus patients that had a suction calibration system used on them during "laparoscopic sleeve gastrectomy" (LSG).

Condition or Disease Intervention/Treatment Phase
  • Device: ViSiGi® 3D suction calibration device
  • Device: Esophagogastroduodenoscopy (EGD) calibration
N/A

Detailed Description

There are multiple choices for a surgeon and their patient when it comes to weight loss surgery. One of those options is a procedure called a "laparoscopic sleeve gastrectomy" (LSG). In this procedure the majority of the patient's stomach is removed leaving behind a stapled "sleeve" about the same size as the patient's esophagus.

During this procedure there are three main devices that surgeon inserts through the mouth and in to the stomach to calibrate the size of the "sleeve". They can use a standard weighted bougie, an endoscope, or a suction calibration device. This study aims to compare the difference in staple usage and post-operative GERD (heartburn) between patients that had an endoscope used versus patients that had a suction calibration system used on them during LSG.

Study Design

Study Type:
Interventional
Actual Enrollment :
125 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison Between Endoscopic vs. Suction Calibration System on Number of Staple Load Firings, Operative Duration, Cost, and Gastro-esophageal Reflux Disease Following Laparoscopic Sleeve Gastrectomy: is There a Difference
Actual Study Start Date :
Jul 30, 2019
Actual Primary Completion Date :
Feb 1, 2022
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: ViSiGi® 3D suction calibration device

The ViSiGi® 3D is the first calibration system specifically intended for use during sleeve gastrectomy.ViSiGi 3D®is a non-sterile, single patient use device. The device comprises a tube with a closed, rounded tip, and holes at the distal end. The proximal end of ViSiGi 3D® includes an integral suction regulator and vented On/Off valve. Advantages of ViSiGi® 3D device include simplification of sleeve calibration in addition to suctioning the stomach and performing leak tests all with one device making operative steps simpler for both the anesthesiology team and surgeons. Since it is single patient use it does not require reprocessing.

Device: ViSiGi® 3D suction calibration device
ViSiGi 3D®is a non-sterile, single patient use device. The device comprises a tube with a closed, rounded tip, and holes at the distal end. The proximal end of ViSiGi 3D® includes an integral suction regulator and vented On/Off valve.

Active Comparator: Esophagogastroduodenoscopy (EGD) calibration

Gastroscope, similar to The ViSiGi device, have suction, calibration, and leak testing capabilities.

Device: Esophagogastroduodenoscopy (EGD) calibration
Gastroscope is an illuminated optical, slender and tubular instrument (a type of borescope) used in esophagogastroduodenoscopy.

Outcome Measures

Primary Outcome Measures

  1. Number of staple load firings [During sleeve gastrectomy (up to 5 hours)]

    Staple usage will be recorded

Secondary Outcome Measures

  1. Operative duration (time) [During sleeve gastrectomy (up to 5 hours)]

    Surgery start and completion time will be recorded, and operative duration will be calculated

  2. Intra-operative cost for patients [During sleeve gastrectomy (up to 5 hours)]

    Cost data (administrative data) will be retrieved from internal database

  3. Change in GERD symptom severity [1-2 months prior to surgery, 3 weeks post-operatively (+/- 2 weeks), 12 months post-operatively (+/- 12 - 24 months)]

    GERD-HRQL questionnaire will be administered pre-operatively and post-operatively. The instrument contains a total of 10 scaled items which are scored, and a patient-reported global satisfaction assessment which is not added to the total GERD-HRQL score. Scale: No symptoms = 0; Symptoms noticeable, but not bothersome = 1; Symptoms noticeable and bothersome, but not every day = 2; Symptoms bothersome every day = 3; Symptoms affect daily activities = 4; Symptoms are incapacitating, unable to do daily activities = 5

  4. Change in body weight [1-2 months prior to surgery, 3 weeks post-operatively (+/- 2 weeks), 12 months post-operatively (+/- 12 - 24 months)]

    Mean % total body weight loss will be calculated

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years old or older

  • agreed with a surgeon that laparoscopic sleeve gastrectomy (LSG) is the best choice

Exclusion Criteria:
  • had prior gastric surgery or bariatric surgery (including prior adjustable gastric band and/or sleeve gastrectomy)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Emory University Hospital Midtown Atlanta Georgia United States 30322

Sponsors and Collaborators

  • Emory University

Investigators

  • Principal Investigator: Elizabeth Hechenbleikner, MD, Emory University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Elizabeth Hechenbleikner, Principal Investigator, Emory University
ClinicalTrials.gov Identifier:
NCT03939819
Other Study ID Numbers:
  • IRB00108907
First Posted:
May 7, 2019
Last Update Posted:
Feb 11, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Elizabeth Hechenbleikner, Principal Investigator, Emory University

Study Results

No Results Posted as of Feb 11, 2022